ZBIO Latest Press Releases

-- October 16, 2026 --

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:15 PM

-- October 12, 2026 --

Zenas BioPharma Announces the Presentation of New Obexelimab Data in IgG4-Related Disease at the 6th International Symposium on IgG4-Related Disease Globe Newswire 7:00 AM

-- October 7, 2026 --

Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis Portfolio Data at MSToronto2026 Globe Newswire 7:05 AM

-- October 6, 2026 --

Zenas BioPharma to Host Virtual R&D Event Globe Newswire 7:05 AM

-- September 22, 2026 --

Zenas BioPharma Announces Upcoming Presentations of Obexelimab Data in IgG4-Related Disease at the IgG4ward! 6th International Symposium on IgG4-Related Disease and ACR Convergence 2026 Globe Newswire 7:05 AM

-- September 18, 2026 --

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:15 PM

-- September 8, 2026 --

Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event Globe Newswire 7:05 AM

-- September 4, 2026 --

Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences Globe Newswire 7:05 AM

-- August 18, 2026 --

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:15 PM

-- August 13, 2026 --

Zenas BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 7:00 AM

-- July 17, 2026 --

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:15 PM

-- June 17, 2026 --

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:15 PM

-- June 11, 2026 --

Zenas BioPharma to Present at the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit Globe Newswire 4:15 PM

Market Data Delayed 15 Minutes